Design Therapeutics Inc.

DSGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.55

+$0.31 (+2.53%)

At close: Sep 21, 2026, 4:00 PM ET

$12.46

-$0.09 (-0.72%)

Pre-market: Sep 22, 2026, 4:45 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.53%

(1D)

Rating

Updated: Sep 1, 2026

13.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $783.84M

1D Range

12.29 12.65

52W Range

5.28 17.25

Valuation (TTM)

PE -10.64

PB 3.88

EV/EBITDA -8.00

Valuation (NTM)

Forward PE N/A

Forward PEG -0.59

Price Target $20.50

Cash Flow

FCF Yield -7.0%

SBC Adj. FCF Yield -8.9%

SBC Impact -26.9%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -13.1% | -4.1%

FCF 3Y | 5Y -3.5% | -3.3%

Returns

ROA -32.9%

ROE -34.0%

ROIC -38.9%

Financial Health

Net Cash

$207.4M

Current Ratio 18.86

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Design Therapeutics, Inc. is a biopharmaceutical company in the preclinical phase that focuses on creating treatments for genetic conditions stemming from nucleotide repeat expansions. Its current pip...

Sector Healthcare

Industry Biotechnology

Employees 55

IPO Date Mar 28, 2021

Website www.designtx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$20.50

Upside

+63.35%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞